Global Hemato Oncology Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR082418545

Publication Date:

August 30, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals" genes for disease, thereby preventing or treating tumours earlier.
Hematologic tumor detection is a technique to detect tumor genes on the basis of gene detection. Blood tumor detection services cover a wide range of solid tumors such as lung cancer, breast cancer, stomach cancer, esophageal cancer, colorectal cancer and liver cancer. Common tumors are detected. According to different tumor stages, blood tumor detection can be divided into four categories: tumor susceptibility gene screening, tumor early diagnosis, tumor individualized drug diagnosis, and tumor recovery monitoring. Tumor susceptibility gene screening can help people at high risk of genetic mutations to actively prevent tumors. Early diagnosis of cancer can help patients to find the disease as early as possible, thus greatly improving the survival rate of cancer patients. Individualized drug diagnosis for cancer patients to provide a more accurate cancer treatment program. Tumor recovery was monitored to assess the risk of recurrence.
In this paper, the current status and future development trend of hematoncology testing in China market are studied, focusing on the analysis of the companies that play an important role in the Chinese market, and focusing on the revenue, market share, market positioning, development plans, products and services of these companies in the Chinese market.
The global Hemato Oncology Testing market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
In Chinese Market, Hemato Oncology Testing key players include Roche, Berry Genomics, Burning Rock Dx, BGI, Genetron, etc. Global top 5 manufacturers hold a share over 28%.
In terms of product, ctDNA Testing is the largest segment, with a share over 71%. And in terms of application, the largest application is Hospital, followed by Third Party Agency, Others.
This report is a detailed and comprehensive analysis for global Hemato Oncology Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Hemato Oncology Testing market size and forecasts, in consumption value ($ Million), 2019-2030
Global Hemato Oncology Testing market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Hemato Oncology Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Hemato Oncology Testing market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hemato Oncology Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hemato Oncology Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Berry Genomics, Burning Rock Dx, BGI, Genetron, Haplox, Amoy Dx, Genosaber, YZY Biopharma, Wondfo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Hemato Oncology Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Hemato Oncology Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
ctDNA Testing
CTC Testing
Other Testing
Market segment by Application
Hospital
Third Party Agency
Others
Market segment by players, this report covers
Roche
Berry Genomics
Burning Rock Dx
BGI
Genetron
Haplox
Amoy Dx
Genosaber
YZY Biopharma
Wondfo
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Hemato Oncology Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hemato Oncology Testing, with revenue, gross margin, and global market share of Hemato Oncology Testing from 2019 to 2024.
Chapter 3, the Hemato Oncology Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Hemato Oncology Testing market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hemato Oncology Testing.
Chapter 13, to describe Hemato Oncology Testing research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hemato Oncology Testing by Type
1.3.1 Overview: Global Hemato Oncology Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Hemato Oncology Testing Consumption Value Market Share by Type in 2023
1.3.3 ctDNA Testing
1.3.4 CTC Testing
1.3.5 Other Testing
1.4 Global Hemato Oncology Testing Market by Application
1.4.1 Overview: Global Hemato Oncology Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Third Party Agency
1.4.4 Others
1.5 Global Hemato Oncology Testing Market Size & Forecast
1.6 Global Hemato Oncology Testing Market Size and Forecast by Region
1.6.1 Global Hemato Oncology Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Hemato Oncology Testing Market Size by Region, (2019-2030)
1.6.3 North America Hemato Oncology Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Hemato Oncology Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Hemato Oncology Testing Market Size and Prospect (2019-2030)
1.6.6 South America Hemato Oncology Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Hemato Oncology Testing Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Hemato Oncology Testing Product and Solutions
2.1.4 Roche Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments and Future Plans
2.2 Berry Genomics
2.2.1 Berry Genomics Details
2.2.2 Berry Genomics Major Business
2.2.3 Berry Genomics Hemato Oncology Testing Product and Solutions
2.2.4 Berry Genomics Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Berry Genomics Recent Developments and Future Plans
2.3 Burning Rock Dx
2.3.1 Burning Rock Dx Details
2.3.2 Burning Rock Dx Major Business
2.3.3 Burning Rock Dx Hemato Oncology Testing Product and Solutions
2.3.4 Burning Rock Dx Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Burning Rock Dx Recent Developments and Future Plans
2.4 BGI
2.4.1 BGI Details
2.4.2 BGI Major Business
2.4.3 BGI Hemato Oncology Testing Product and Solutions
2.4.4 BGI Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 BGI Recent Developments and Future Plans
2.5 Genetron
2.5.1 Genetron Details
2.5.2 Genetron Major Business
2.5.3 Genetron Hemato Oncology Testing Product and Solutions
2.5.4 Genetron Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Genetron Recent Developments and Future Plans
2.6 Haplox
2.6.1 Haplox Details
2.6.2 Haplox Major Business
2.6.3 Haplox Hemato Oncology Testing Product and Solutions
2.6.4 Haplox Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Haplox Recent Developments and Future Plans
2.7 Amoy Dx
2.7.1 Amoy Dx Details
2.7.2 Amoy Dx Major Business
2.7.3 Amoy Dx Hemato Oncology Testing Product and Solutions
2.7.4 Amoy Dx Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Amoy Dx Recent Developments and Future Plans
2.8 Genosaber
2.8.1 Genosaber Details
2.8.2 Genosaber Major Business
2.8.3 Genosaber Hemato Oncology Testing Product and Solutions
2.8.4 Genosaber Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Genosaber Recent Developments and Future Plans
2.9 YZY Biopharma
2.9.1 YZY Biopharma Details
2.9.2 YZY Biopharma Major Business
2.9.3 YZY Biopharma Hemato Oncology Testing Product and Solutions
2.9.4 YZY Biopharma Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 YZY Biopharma Recent Developments and Future Plans
2.10 Wondfo
2.10.1 Wondfo Details
2.10.2 Wondfo Major Business
2.10.3 Wondfo Hemato Oncology Testing Product and Solutions
2.10.4 Wondfo Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Wondfo Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hemato Oncology Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Hemato Oncology Testing by Company Revenue
3.2.2 Top 3 Hemato Oncology Testing Players Market Share in 2023
3.2.3 Top 6 Hemato Oncology Testing Players Market Share in 2023
3.3 Hemato Oncology Testing Market: Overall Company Footprint Analysis
3.3.1 Hemato Oncology Testing Market: Region Footprint
3.3.2 Hemato Oncology Testing Market: Company Product Type Footprint
3.3.3 Hemato Oncology Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Hemato Oncology Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Hemato Oncology Testing Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Hemato Oncology Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Hemato Oncology Testing Market Forecast by Application (2025-2030)
6 North America
6.1 North America Hemato Oncology Testing Consumption Value by Type (2019-2030)
6.2 North America Hemato Oncology Testing Market Size by Application (2019-2030)
6.3 North America Hemato Oncology Testing Market Size by Country
6.3.1 North America Hemato Oncology Testing Consumption Value by Country (2019-2030)
6.3.2 United States Hemato Oncology Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Hemato Oncology Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Hemato Oncology Testing Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Hemato Oncology Testing Consumption Value by Type (2019-2030)
7.2 Europe Hemato Oncology Testing Consumption Value by Application (2019-2030)
7.3 Europe Hemato Oncology Testing Market Size by Country
7.3.1 Europe Hemato Oncology Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Hemato Oncology Testing Market Size and Forecast (2019-2030)
7.3.3 France Hemato Oncology Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Hemato Oncology Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Hemato Oncology Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Hemato Oncology Testing Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Hemato Oncology Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Hemato Oncology Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Hemato Oncology Testing Market Size by Region
8.3.1 Asia-Pacific Hemato Oncology Testing Consumption Value by Region (2019-2030)
8.3.2 China Hemato Oncology Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Hemato Oncology Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Hemato Oncology Testing Market Size and Forecast (2019-2030)
8.3.5 India Hemato Oncology Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Hemato Oncology Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Hemato Oncology Testing Market Size and Forecast (2019-2030)
9 South America
9.1 South America Hemato Oncology Testing Consumption Value by Type (2019-2030)
9.2 South America Hemato Oncology Testing Consumption Value by Application (2019-2030)
9.3 South America Hemato Oncology Testing Market Size by Country
9.3.1 South America Hemato Oncology Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Hemato Oncology Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Hemato Oncology Testing Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Hemato Oncology Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Hemato Oncology Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Hemato Oncology Testing Market Size by Country
10.3.1 Middle East & Africa Hemato Oncology Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Hemato Oncology Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Hemato Oncology Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Hemato Oncology Testing Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Hemato Oncology Testing Market Drivers
11.2 Hemato Oncology Testing Market Restraints
11.3 Hemato Oncology Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Hemato Oncology Testing Industry Chain
12.2 Hemato Oncology Testing Upstream Analysis
12.3 Hemato Oncology Testing Midstream Analysis
12.4 Hemato Oncology Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Roche
Berry Genomics
Burning Rock Dx
BGI
Genetron
Haplox
Amoy Dx
Genosaber
YZY Biopharma
Wondfo

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂